New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 24, 2014
08:31 EDTREXMY, BERYBerry Plastics offers to acquire Rexam's Healthcare C&C business for $135M
Berry Plastics Group (BERY) announced that it has entered into a definitive agreement to acquire the U.S., Mexico, and India portions of Rexam’s (REXMY) Healthcare Containers and Closures business. Berry Plastics has also made a binding offer to purchase the French portion of Rexam’s C&C business, which Rexam may accept after completion of the required consultation process with the works council in France. Upon completion of both transactions, Berry Plastics would pay approximately $135M for the entire Healthcare Containers and Closures business unit, with the closing expected to take place in the second calendar quarter of 2014. The company expects the acquisition, which will be funded from existing liquidity, to be deleveraging after achieving synergies. The Healthcare Containers and Closures business produces bottles, closures and specialty products for pharmaceutical and OTC applications. The transaction includes eight manufacturing locations - five in the United States and one each in Mexico, France, and India, with total employment of approximately 1,500 and 2013 sales of $262M.
News For BERY;REXMY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 1, 2015
13:37 EDTBERYBerry Plastics completes purchase of AVINTIV for $2.45B
Subscribe for More Information
06:25 EDTREXMYEU regulators express concerns over Ball-Rexam deal, WSJ reports
EU regulators have sent a list of concerns to Ball Corp. (BLL) over its proposed $6.6B takeover of Rexam (REXMY) as part of an investigation into whether the deal could lead to higher prices for beverage cans, the Wall Street Journal reports. The move will force Ball to come forward with concessions, such as asset sales, in order to allay the regulator's concerns, the report says. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use